EMEA-000322-PIP01-08-M05
Key facts
| Invented name |
Cystadrops
|
| Active substance |
Cysteamine (hydrochloride)
|
| Therapeutic area |
Ophthalmology
|
| Decision number |
P/0172/2017
|
| PIP number |
EMEA-000322-PIP01-08-M05
|
| Pharmaceutical form(s) |
|
| Condition(s) / indication(s) |
Treatment of corneal cystine crystal deposits in cystinosis
|
| Route(s) of administration |
Ocular use
|
| Contact for public enquiries |
Orphan Europe SARL
|
| Decision type |
PM: decision on the application for modification of an agreed PIP
|